• Content Count

  • Joined

  • Last visited

  • Days Won


About FrFan

  • Rank
    The Playmaker

Contact Methods

  • Website URL

Profile Information

  • Birthdate
  • Interests
    Travels, computers, ethnology, scuba-diving, Sci-Fi.
  • Redskins Fan Since
  • Favorite Redskin
    John Riggins
  • Not a Skins Fan? Tell us YOUR team:
  • Location
  • Zip Code
  • Interests
    Scubadiving, travels, technology, computers, Sci-Fi, ethnology.
  • Occupation

Recent Profile Visitors

26,241 profile views
  1. NEJM, Lancet place expressions of concern on controversial studies of drugs for COVID-19 The article, “Compassionate use of remdesivir for patients with severe Covid-19,” appeared in in April and immediately triggered waves of both enthusiasm and skepticism. The researchers reported that: In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy. (Funded by Gilead Sciences.) Not surprisingly, the paper received an avalanche of page views, press coverage and attention on social media. It even prompted an open letter from Daniel O’Day, the CEO of Gilead, which makes the drug, sponsored the study and wrote “earlier versions” of the manuscript. Surgisphere: governments and WHO changed Covid-19 policy based on suspect data from tiny US company A search of publicly available material suggests several of Surgisphere’s employees have little or no data or scientific background. An employee listed as a science editor appears to be a science fiction author and fantasy artist whose professional profile suggests writing is her fulltime job. Another employee listed as a marketing executive is an adult model and events hostess, who also acts in videos for organisations.
  2. "Little Chef' charms Myanmar with lockdown cooking classes
  3. Computer science and medical imaging to show the coronavirus in 3D. Anakinra for severe forms of COVID-19: a cohort study Be aware it's been published in The Lancet !
  4. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals CD4+ T cell responses were detected in 40%–60% of unexposed individuals. This may be reflective of some degree of cross-reactive, preexisting immunity to SARS-CoV-2 in some, but not all, individuals. Whether this immunity is relevant in influencing clinical outcomes is unknown—and cannot be known without T cell measurements before and after SARS-CoV-2 infection of individuals—but it is tempting to speculate that the cross-reactive CD4+ T cells may be of value in protective immunity, based on SARS mouse models (Zhao et al., 2016). Japanese firm claims success against COVID-19
  5. Snowpiercer : Remnants of humanity live in a perpetually moving train after the world becomes a frozen wasteland in this futuristic drama that's based on the 2013 film. After second episode the serie looks like a "train detective", and Jennifer Connelly is gorgeous
  6. Crossed immunity between cold coronaviruses and SARS-CoV-2: the end of the pandemic?
  7. FWIW I hope it's going to be lower than the lower number
  8. Mehra from The Lancet Dr. Mehra is a consultant for Abbott, Medtronic, Janssen (a division of Johnson and Johnson), Stealth Biotherapeutics, Teva (now Mesoblast), NupulseCV, Inc., Portola, Xogenex, Bayer; and is on the Scientific Advisory Board for NupulseCV and FineHeart
  9. COVID-19 situation update worldwide, as of 25 May 2020
  10. Are the numbers accurate ? How many people got tested ? I believe many cases haven't been reported too. If few people are tested, the fatality rate immediately seems very high.
  11. Sincere condolances may he/she rest in peace.